Pricing & Reimbursement
Please see German version for further presentations.
Szczesny, Josephine; Tasler, Johanna; Leismann, Janine; Ecker, Thomas
„Re-assessment of orphan drugs in Germany after exceeding the annual sales limit of € 30 million: Impact on the reimbursement price and key influencing factors?“
Poster presentation at ISPOR Europe, November 2025
Bot, Danny; Leismann, Janine; Beenk, Katharina; Ecker, Thomas
“How do the stricter pricing regulations of the Statutory Health Insurance Financial Stabilization Act (“GKV-FinStG”) affect reimbursement prices of new drugs in Germany?"
Poster presentation at ISPOR Europe, November 2023
Natz, Alexander; Ecker, Thomas; Bot, Danny
"Drastic Changes in Europe’s 1st Launch Country: How recent legislative changes impact the German pricing and reimbursement landscape"
Webinar hosted by EUCOPE and Ecker + Ecker, March 2023
Bot, Danny; Ecker, Thomas; Linstaedt, Justine
"Effect of new indications on the price development of new medicinal products in Germany”
Poster presentation at ISPOR Europe, November 2018
Fink, Carolin; Ecker, Christof
"Importance of Tendering after Patent Expiry in Germany"
Poster presentation at ISPOR Europe, November 2017